RadiotherapyPelvic NeoplasmsPelvisChemotherapy, AdjuvantRadiotherapy, AdjuvantRadiotherapy DosageRadiation InjuriesCombined Modality TherapyAdjuvants, ImmunologicSemustineRectal NeoplasmsAntidiarrhealsAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalBreast NeoplasmsTamoxifenRadiotherapy, ConformalNeoplasm StagingBrachytherapyFreund's AdjuvantTreatment OutcomeFluorouracilRadiation DosageNeoplasm Recurrence, LocalUterine Cervical NeoplasmsRadiation, IonizingDose-Response Relationship, RadiationRadiotherapy, Intensity-ModulatedAntineoplastic Agents, HormonalRadiotherapy Planning, Computer-AssistedAdenocarcinomaCisplatinCyclophosphamideLevamisoleRadiation ToleranceRadiotherapy, High-EnergyMastectomyDoxorubicinMastectomy, SegmentalLeucovorinSurvival AnalysisRadiation OncologyDose FractionationLymphatic MetastasisAdjuvants, PharmaceuticFollow-Up StudiesPrognosisRadiationRadiotherapy, Computer-AssistedSurvival RateRadiotherapy, Image-GuidedSelective Estrogen Receptor ModulatorsRadiation ProtectionColonic NeoplasmsClinical Trials as TopicRandomized Controlled Trials as TopicEstrogen Receptor ModulatorsRaloxifeneRadiation MonitoringMethotrexateReceptors, EstrogenDrug Administration ScheduleRadiation PneumonitisNeoplasms, Radiation-InducedRetrospective StudiesRadiosurgeryHead and Neck NeoplasmsRadiation-Sensitizing AgentsOrganoplatinum CompoundsRadiometryBrain NeoplasmsNeoplasms, Hormone-DependentProportional Hazards ModelsChemoradiotherapyAntineoplastic AgentsTime FactorsCarcinoma, Squamous CellRadiation Injuries, ExperimentalAluminum HydroxideRisk AssessmentAntibodies, Monoclonal, HumanizedNasopharyngeal NeoplasmsGamma RaysParticle AcceleratorsRadiation-Protective AgentsRadiodermatitisOrgans at RiskNeoadjuvant TherapyLung NeoplasmsCranial IrradiationCosmic RadiationImmunizationCobalt RadioisotopesTomography, X-Ray ComputedNeoplasmsMice, Inbred BALB CDacarbazineNeoplasms, Second PrimaryKaplan-Meier EstimateVincristine